Data / Form D filings / Applied Bioresearch, Inc.
Applied Bioresearch, Inc.: Form D filings
Applied Bioresearch, Inc., a pharmaceuticals company in Draper, UT, filed 3 Form D notices with the SEC between 2012 and 2014. The latest, on June 2, 2014, reports an offering of $750,000 with nothing sold yet.
Find out what Applied Bioresearch, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12685 SOUTH 125 EAST, Draper, UT, 84020
- Phone
- (801) 514-5786
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Utah
- Year incorporated
- 2011
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1557717
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2014 | New notice | $750,000 | $0 | $750,000 | 0 | Yet to occur | sec.gov |
| May 24, 2013 | New notice | $500,000 | $50,000 | $450,000 | 2 | May 10, 2013 | sec.gov |
| Sep 7, 2012 | New notice | $250,000 | $250,000 | $0 | 6 | Aug 13, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kendal Edwin Svedeen | Executive Officer, Director |
Every Form D from the week of Jun 2, 2014 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Applied Bioresearch, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.